Regular paperDistribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization
References (28)
- et al.
Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation
Neuron
(1992) - et al.
Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain
Eur. J. Pharmacol.
(1992) - et al.
Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV)
Gene
(1988) - et al.
Terminal transferase-catalyzed addition of nucleotides to the 3′ termini of DNA
Methods Enzymol.
(1980) - et al.
Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates
Neurosci. Lett.
(1993) - et al.
C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine
Eur. J. Pharmacol.
(1993) - et al.
Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion
Mol. Brain Res.
(1994) - et al.
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA
- et al.
Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons
Nature
(1990) - et al.
Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line
Mol. Endocrinol.
(1992)
Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions
Nature
(1993)
Suppression of ischemia-induced Fos expression and AP-1 activity by an antisense oligonucleotide to c-fos mRNA
Ann. Neurol.
(1994)
NMDA receptor inhibition using antisense oligonucleotides prevents delayed neuronal death in gerbil hippocampus following cerebral ischemia
Neurosci. Res. Commun.
(1994)
Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system
Cited by (47)
MiR-128-3p – a gray eminence of the human central nervous system
2024, Molecular Therapy Nucleic AcidsAntisense oligonucleotides in therapy for neurodegenerative disorders
2015, Advanced Drug Delivery ReviewsProduction of truncated protein by the crosslink formation of mRNA with 2′-OMe oligoribonucleotide containing 2-amino-6-vinylpurine
2012, Bioorganic and Medicinal Chemistry LettersThe uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivo
2005, Journal of Neuroscience MethodsInhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons
2005, Experimental NeurologyTen years of antisense inhibition of brain G-protein-coupled receptor function
2003, Brain Research Reviews
Copyright © 1995 Published by Elsevier B.V.